Groww Logo
Home>US Stocks>Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

Healthcare
$0.98
- $0.09 (8.40%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $1.08$1.07511,199340,353

      Fundamentals

      Market Cap$41.70M
      P/B Ratio0.3
      P/E Ratio-0.7
      Enterprise Value$-73.60M
      Div. Yield0.00%
      Book Value2.36
      EPS(TTM)-0.28
      ROENA
      Understand Fundamentals

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Neoleukin Therapeutics, Inc.

      Can I Buy Neoleukin Therapeutics, Inc. Shares in India?

      Yes, Neoleukin Therapeutics, Inc. shares can be bought in India by opening an international trading account with Groww.

      How to Buy Neoleukin Therapeutics, Inc. Shares in India?

      One can easily invest in Neoleukin Therapeutics, Inc. shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Neoleukin Therapeutics, Inc. shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Neoleukin Therapeutics, Inc..

      What is the Share Price of Neoleukin Therapeutics, Inc.?

      The share price of Neoleukin Therapeutics, Inc. is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Neoleukin Therapeutics, Inc. share price is $0.98 as of 15 May ‘22

      What is the Market Cap of Neoleukin Therapeutics, Inc.?

      The Neoleukin Therapeutics, Inc. market cap is $41.70M as of 15 May ‘22

      What is the PE and PB ratio of Neoleukin Therapeutics, Inc.?

      The PE and PB ratio of Neoleukin Therapeutics, Inc. is -0.7 and 0.3 as of 15 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.7
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW